Sirois P - Search Results

1

Effects of angiotensin-converting enzyme inhibitor plus irbesartan on maximal and submaximal exercise capacity and neurohumoral activation in patients with congestive heart failure.

Blanchet M, Sheppard R, Racine N, Ducharme A, Curnier D, Tardif JC, Sirois P, Lamoureux MC, De Champlain J, White M. Blanchet M, et al. Among authors: sirois p. Am Heart J. 2005 May;149(5):938.e1-7. doi: 10.1016/j.ahj.2004.11.011. Am Heart J. 2005. PMID: 15894946 Clinical Trial.

2

Neurohormonal activation in severe heart failure: relations to patient death and the effect of treatment with flosequinan.

Moe GW, Rouleau JL, Charbonneau L, Proulx G, Arnold JM, Hall C, de Champlain J, Barr A, Sirois P, Packer M. Moe GW, et al. Among authors: sirois p. Am Heart J. 2000 Apr;139(4):587-95. doi: 10.1016/s0002-8703(00)90035-8. Am Heart J. 2000. PMID: 10740139 Clinical Trial.

3

Changes in vasoconstrictive hormones, natriuretic peptides, and left ventricular remodeling soon after anterior myocardial infarction.

White M, Rouleau JL, Hall C, Arnold M, Harel F, Sirois P, Greaves S, Solomon S, Ajani U, Glynn R, Hennekens C, Pfeffer M. White M, et al. Among authors: sirois p. Am Heart J. 2001 Dec;142(6):1056-64. doi: 10.1067/mhj.2001.119612. Am Heart J. 2001. PMID: 11717612 Clinical Trial.

4

Endothelin A receptor blockade causes adverse left ventricular remodeling but improves pulmonary artery pressure after infarction in the rat.

Nguyen QT, Cernacek P, Calderoni A, Stewart DJ, Picard P, Sirois P, White M, Rouleau JL. Nguyen QT, et al. Among authors: sirois p. Circulation. 1998 Nov 24;98(21):2323-30. doi: 10.1161/01.cir.98.21.2323. Circulation. 1998. PMID: 9826321

5

Triple vasopeptidase inhibition of angiotensin-converting enzyme/neutral endopeptidase/endothelin-converting enzyme activities on the hemodynamic profile of chronically instrumented unrestrained conscious spontaneously hypertensive rats.

Daull P, Blouin A, Sirois P, Nantel F, Jeng AY, Battistini B. Daull P, et al. Among authors: sirois p. J Cardiovasc Pharmacol. 2004 Nov;44 Suppl 1:S398-401. doi: 10.1097/01.fjc.0000166293.79948.09. J Cardiovasc Pharmacol. 2004. PMID: 15838331

6

Triple vasopeptidase inhibition normalizes blood pressure in conscious, unrestrained, and spontaneously hypertensive rats.

Daull P, Benrezzak O, Arsenault D, Pheng LH, Blouin A, Cayer J, Beaudoin M, Belleville K, Sirois P, Nantel F, Jeng AY, Battistini B. Daull P, et al. Among authors: sirois p. Am J Hypertens. 2005 Dec;18(12 Pt 1):1606-13. doi: 10.1016/j.amjhyper.2005.06.022. Am J Hypertens. 2005. PMID: 16364833

7

The first preclinical pharmacotoxicological safety assessment of CGS 35601, a triple vasopeptidase inhibitor, in chronically instrumented, conscious, and unrestrained spontaneously hypertensive rats.

Daull P, Lepage R, Benrezzak O, Cayer J, Beaudoin M, Belleville K, Blouin A, Sirois P, Nantel F, Jeng AY, Battistini B. Daull P, et al. Among authors: sirois p. Drug Chem Toxicol. 2006;29(2):183-202. doi: 10.1080/01480540600566717. Drug Chem Toxicol. 2006. PMID: 16707327

8

Angiotensin converting enzyme inhibition and autoregulation of glomerular filtration.

Plante GE, Chainey A, Sirois P, Devissaguet M. Plante GE, et al. Among authors: sirois p. J Hypertens Suppl. 1988 Dec;6(3):S69-73. J Hypertens Suppl. 1988. PMID: 3066878

9

Effects of dual endothelin-converting enzyme/neutral endopeptidase inhibitors, CGS 26303 and CGS 26393, on lipopolysaccharide or interleukin-1 beta-stimulated release of endothelin from guinea pig tracheal epithelial cells.

Pelletier S, Battistini B, Jeng AY, Sirois P. Pelletier S, et al. Among authors: sirois p. J Cardiovasc Pharmacol. 1998;31 Suppl 1:S10-2. doi: 10.1097/00005344-199800001-00005. J Cardiovasc Pharmacol. 1998. PMID: 9595386

10

The hemodynamic and metabolic profiles of Zucker diabetic fatty rats treated with a single molecule triple vasopeptidase inhibitor, CGS 35601.

Daull P, Blouin A, Beaudoin M, Gadbois S, Belleville K, Cayer J, Berthiaume N, Sirois P, Nantel F, Jeng AY, Battistini B. Daull P, et al. Among authors: sirois p. Exp Biol Med (Maywood). 2006 Jun;231(6):824-9. Exp Biol Med (Maywood). 2006. PMID: 16741006

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

421 results

Search Page